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Measuring growth and obesity across childhood and adolescence
H. David McCarthy
Public Health Nutrition Research Group, Faculty of Life Sciences & Computing, London Metropolitan University,
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The dramatic rise in childhood obesity has driven the demand for tools better able to assess
and deﬁne obesity and risk for related co-morbidities. In addition, the early life origins of
non-communicable diseases including type 2 diabetes are associated with subtle alterations
in growth and body composition, including total and regional body fatness, limb/trunk
length and skeletal muscle mass (SMM). Consequently improved tools based on national
reference data, which capture these body components must be developed as the limitations
of BMI as a measure of overweight and obesity and associated cardiometabolic risk are
now recognised. Furthermore, waist circumference as a measure of abdominal fatness in
children is now endorsed by the International Diabetes Federation and National Institute
for Clinical and Health Excellence for diagnostic and monitoring purposes. The present
paper aims to review the research on growth-related variations in body composition and pro-
portions, together with how national references for percentage body fat, SMM and leg/trunk
length have been developed. Where collection of these measures is not possible, alternative
proxy measures including thigh and hip circumferences are suggested. Finally, body ratios
including the waist:height and muscle:fat ratios are highlighted as potential measures of
cardiometabolic disease risk. In conclusion, a collection of national references for individual
body measures have been produced against which children and youths can be assessed.
Collectively, they have the capacity to build a better picture of an individual’s pheno-
type, which represents their risk for cardiometabolic disease beyond that of the capability
of BMI.
Children: Growth: Obesity: BMI: Waist: Skeletal muscle: Centile charts:
Cardiometabolic risk
Within the disciplines of child health and nutrition,
growth measurement has historically performed import-
ant clinical and public health functions, being an indi-
cator of feeding and environmental circumstances of
infants and children. As a result, tools have been devel-
oped to identify and monitor children and infants dis-
playing poor growth, failure to thrive and malnutrition.
These tools, mainly in the form of growth charts and ref-
erence data are still very much in use today, with con-
tinuing improvements in their diagnostic ability(1).
However, in the 21st century, a completely different
nutritional and physical environment exists, whereby in
countries such as Ireland and the UK, there is less of a
problem with poor growth and under nutrition, but
now a near epidemic of overweight and obesity. Thus,
our focus has had to switch to measuring what could
be termed ‘overgrowth’ in the form of excess body fat.
Consequently, the tools needed to measure obesity have
also had to adapt and improve to meet the requirements
for population surveillance and clinical identiﬁcation.
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Despite this shift in focus, the requirements for assess-
ment tools remain unchanged, in that techniques should
be simple, quick and inexpensive to perform, yet still
meet the demands for accuracy, reproducibility, sensi-
tivity and speciﬁcity. There is a need to avoid the misclass-
iﬁcation of individuals and for the measure to be
strongly related to morbidity or risk for later disease
especially cardiometabolic disease. Indeed the leading
causes of deaths in England and Wales in men aged 35
and above, and in women aged 65 and above is attribu-
ted to CHD and in the 35–64 years age range in women
it is breast cancer(2). Both of these non-communicable
diseases have strong links with body composition es-
pecially excess body fat, obesity and body fat
distribution.
Early growth, obesity and chronic disease risk
There is an additional dimension to measuring growth
and obesity since it is now recognised that growth
patterns and nutritional experience during fetal develop-
ment and across infancy and childhood are associated
with later risk for components of the metabolic syn-
drome, including type 2 diabetes, dyslipidaemia, non-
alcoholic steatohepatitis (fatty liver) and hypertension.
Much of this evidence has stemmed from the original epi-
demiological studies of Professor David Barker and his
team where this pioneering research demonstrated a
link between low birth weight and low weight at the
age of 1 and later risk for hypertension, type 2 diabetes
and CHD(3). As an alternative to the thrifty genotype
hypothesis for risk for type 2 diabetes, the thrifty pheno-
type hypothesis stemmed from the Barker studies. This
hypothesis suggests that type 2 diabetes risk could
arise, in part, through a non-genetic, vertical trans-
mission from mother to offspring, whereby metabolic
adaptation occurs during fetal life and early infancy.
Here, it is proposed that a sensing of a nutritionally
poor environment in utero triggers the fetus to adapt its
metabolism in a direction better able to aid survival
and withstand a similar nutritional environment post-
natally. However, a conﬂict between this altered setting
and exposure to an environment where food energy avail-
ability is abundant and demands for physical activity are
low could set the individual on a life course trajectory to
type 2 diabetes and cardiometabolic disease(4).
Body composition, body dimensions and proportionality
With respect to patterns of physical growth, such an ad-
aptation can also be reﬂected in subtle changes in body
composition, including body fat distribution and body
proportions and dimensions, which cannot always be
easily identiﬁed and quantiﬁed by some assessment
tools with poor sensitivity. Over the past 20 years, how-
ever, this initial hypothesis has become reﬁned, with
one key newer suggestion being that a lower birth weight
coupled with a rapid post-natal growth (or rapid
post-natal growth alone) promotes the accumulation of
excess visceral adipose tissue mass and its associated
risk for obesity-related morbidity(5). Thus, when asses-
sing and characterising growth and obesity, the tools
should be able to capture both elements while ensuring
they are also able to associate these measurements to
the phenotype associated with cardiometabolic disease
risk. Up until very recently, the accurate characterisation
of this phenotype has been constrained by the lack of
sensitive and accurate assessment tools. For example, in-
fant and child growth can proceed at different rates,
depending largely on the post-natal diet and environ-
ment, and can be quantiﬁed using weight-for-age and
height-for-age charts.
BMI and BMI centile charts
The BMI and BMI charts based on reference data are
used to classify individuals across childhood and ado-
lescence that are underweight, of a healthy weight, over-
weight and obese. These classiﬁcations can be statistically
based, typically with the 91st and 98th centiles used to
deﬁne overweight and obese children, and the 2nd centile
to deﬁne underweight(6). This form of classiﬁcation
has been improved through the development of the
International Obesity Task Force (IOTF) cut-offs,
where the centile curves deﬁning overweight and obesity
pass through the adult BMI cut-offs of 25 and 30 at
age 18 years(7). However, such assessment tools give no
indication of the partitioning of dietary energy and
nitrogen across growth into fat- and fat-free tissues; a
division that can determine later disease risk. Further-
more, looking more closely at what lies behind BMI indi-
cates that this measurement reﬂects a composite of a
number of aspects of body composition and proportion,
which individually can reﬂect variations in patterns of
growth and disease risk. For example, within the BMI
the following components of body structure and compo-
sition are amalgamated: Skeletal (bone) mass; Skeletal
muscle mass (SMM); Organ mass; Adipose tissue mass;
Body fat distribution; Limb length; Trunk length;
Hydration of the fat-free mass; Stature.
Some of these components are known to have recipro-
cal effects on disease risk. For example (see later for
more details), skeletal muscle and adipose tissue have op-
posing effects on insulin sensitivity and energy disposal
and a deﬁcit in muscle mass coupled with an excess of
adipose mass could balance out each other with respect
to body weight, with the possibility of leading the BMI
to classify a child within the healthy range. Thus, the
BMI is limited at an individual level as it correlates
with both fat mass and fat-free mass, it has a low sensi-
tivity, i.e. it fails to identify relatively large numbers
of children with excess fat and it can underestimate
obesity prevalence by the creation of false negatives.
Furthermore, the BMI gives no indication of body fat
distribution. This is important as an upper body or ab-
dominal distribution of body fat carries a greater risk
for cardiometabolic disease due to the accumulation of
excess visceral adipose tissue, fat tissue with greater lipo-
lytic activity drained by the portal system and with
Measuring growth and obesity across childhood and adolescence 211
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0029665113003868
Downloaded from https://www.cambridge.org/core. London Metropolitan University, on 08 Nov 2018 at 16:03:44, subject to the Cambridge Core terms of use, available at
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
increased release of NEFA. This raised fatty acid release
is considered a key contributor to decreased insulin sen-
sitivity. These limitations of BMI are widely acknowl-
edged but largely ignored. Nevertheless in the UK, the
formal guidelines on obesity assessment produced by
the National Institute for Clinical and Health Excellence
(NICE) recommend the use of BMI as a practical esti-
mate in children, even though it concedes that it should
be interpreted with caution as it is not a direct measure
of adiposity(8). Thus, in child obesity surveillance such
as the National Child Measurement Programme where
BMI is the assessment tool used, prevalence ﬁgures can
be under-reported, especially in areas of the country,
for example, where a large proportion of children from
South Asian backgrounds reside(9). This stems from the
observation that the South Asian phenotype is charac-
terised by a higher fat mass with a more abdominal dis-
tribution of body fat and a lower SMM compared with
white Europeans of the same BMI for age. Consequently,
the WHO has now formally lowered the BMI thresholds
for deﬁning overweight (BMI=23) and obesity (BMI=
25) in South Asian adults(10). These lowered thresholds
should also translate into lower BMI centile cut-offs to
deﬁne overweight and obesity in South Asian childhood
populations. However, a review of the evidence up to
2010 led to the conclusion that there was insufﬁcient evi-
dence to support separate BMI deﬁnitions for obesity in
children and adolescents from South Asian ethnic groups
in the UK(11). With advancing technological ability to
characterise further the body composition of children
and youths, together with evidence arising out of clinical
referrals for type 2 diabetes diagnoses in children and
youths from this ethnic background, it may well be
timely to revisit this position, especially as one of the
aims of developing assessment tools is to make them eas-
ily understandable and as user friendly as possible. A
lack of harmonisation between child/adolescent and
adult systems illustrates a major limitation with the cur-
rent separate systems. For example upon reaching age 18,
an individual of South Asian origin with a BMI of 25
would be classiﬁed using the IOTF cut-off as borderline
healthy weight/overweight before the 18th birthday; but
then switching to the adult system at age 18, the individ-
ual would now be classiﬁed as obese without any change
in their BMI. Such are the limitations of BMI that its use
in children and youths has now been brought to the at-
tention of the general public through proﬁling of the
issue within the media, with one prominent child obesity
researcher claiming ‘it’s just not a sufﬁciently sensitive
measure’(12). This statement mirrors similar observations
in adults where it has been shown that in the USA, the
prevalence of obesity is drastically underestimated
when BMI is used compared with the more sophisticated
technology of dual energy X-ray absorptiometry(13).
Abdominal adiposity and waist circumference
centile charts
The recognition that abdominal adiposity and visceral
fat relate to cardiometabolic disease risk in children
and youths dates back to the mid-1990s. Prior to that
time, it was assumed that abdominal obesity was a
phenomenon of adulthood, especially the accumulation
of excess visceral fat. However, the correlation of waist
circumference (WC) with visceral fat accumulation in
children has been demonstrated(14) and several studies
beginning around the mid-1990s demonstrated that WC
was a sensitive marker for several components of cardio-
metabolic disease. WC has been shown to be indepen-
dently related to an adverse atherogenic lipoprotein
proﬁle in 12–14 year olds(15) and an adverse (raised) fast-
ing insulin concentration in 5–17 year olds(16). More re-
cent studies have extended the relationship between
WC and cardiometabolic disease components in children
to include non-alcoholic fatty liver disease (non-alcoholic
steatohepatitis)(17), elevated blood pressure(18), markers
of inﬂammation(19) and a clustering of components of
the metabolic syndrome(20). Such observations have led
to a demand for national references for WC in children
and youths to be produced, which could be used in
both clinical and epidemiological contexts. The UK
WC charts were produced in 2001(21) followed by a glo-
bal expansion of equivalent charts in more than twenty
countries, with some of the most recent additions includ-
ing Malaysia, Germany and Poland(22–24). Despite this
expansion in awareness and utility of WC in obesity
and cardiometabolic disease risk assessment, there re-
mains a reluctance to fully embrace this assessment
tool by some formal authorities. For example, NICE
obesity guidelines state that WC is not recommended
as a routine measure in children and youths but concedes
that it may be used to give additional information on
risk of developing long-term health problems, preferring
instead to support the continued use of BMI(8).
Paradoxically, the recent NICE clinical guidelines on
psychosis and schizophrenia in children and young
people (CG155), recommend the monitoring of WC
and hip circumference (HC) and use of WC and HC
centile charts for patients receiving anti-
psychotic drugs, due to the known effect of this type
of pharmacotherapy on weight gain(25). More encoura-
gingly, the International Diabetes Federation supports
the measurement of abdominal obesity as the ‘sine
qua non’ for the diagnosis of metabolic syndrome in
children and adolescents. It bases this statement on the
data relating WC with components of the metabolic
syndrome in children and the unequivocal evidence of
the dangers of abdominal obesity in adulthood. The
International Diabetes Federation states the WC>90th
centile cut-off as the diagnostic criterion as several
studies have shown that these children are more likely
to have multiple risk factors than those with a WC
below this level(26). A further potential improvement to
the 90th WC centile cut-off has been the recent develop-
ment of centiles for UK children which pass through the
adult WC cut-offs at age 18 which relate to ‘increased
risk’ (94cm men, 80cm women) and ‘high risk’
(102cm men, 88cm women)(27). Such centiles are the
equivalent to the IOTF BMI cut-offs and research is cur-
rently being conducted to evaluate the effectiveness of
these new centiles.
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Body fatness, body fat centile charts and bioimpedance
technology
Up to this point, bothBMIandWCareused as proxymea-
sures of total and abdominal adiposity. The ideal assess-
ment tool should directly assess adiposity particularly
since pathology is driven, in part by excess adipose mass.
However, until recently it has been difﬁcult to quantify
fat mass outside the laboratory but improvements in bio-
electrical impedance technology and its incorporation
into step-on scales have taken the assessment of fat and
lean masses into the clinical and community settings.
Although slightly less accurate compared with the more
sophisticated laboratory techniques, they offer practical
advantages in being simple to use, with a relatively low
cost. Thus in 2006, the ﬁrst body fat centile charts based
on bioelectrical impedance analysis (BIA) technology
were produced for the UK child and youth population(28).
These charts clearly illustrate the gender differences in total
body fat accumulation as well as the pattern of accumu-
lation across childhood and adolescence; differences that
are obscured inBMI charts. Indeed, the shape of the curves
matches the expected changes in body fat patterning
across human growth and clearly illustrates the pubertal
inﬂuences in boys and girls. These charts show, for exam-
ple, that at age 18 girls have proportionately 60% more
body fat than boys, with the median per cent values
being 24·6 and 15·4%, respectively. Furthermore, to
deﬁne useful cut-offs for clinically and epidemiologically
purposes that broadly agree with the IOTF BMI cut-offs,
the 85th and 95th centiles provided a reasonably close
approximation to the IOTF overweight and obese bound-
aries, with the 2nd centile chosen to approximate the IOTF
underweight equivalent. Thus these body fat boundaries
deﬁne underfat, normal, overfat and obese. We are now
seeing body fat centile charts emerging in other paediatric
populations, for example, in Hong Kong and Turkish
children(29,30), suggesting the wider recognition of the
importance of body fat assessment. One additional advan-
tage of body fat charts over BMI charts is the reduction
in the misclassiﬁcation of children who can be categorised
as healthy by the BMI despite having excess body fat.
Similarly, large framed or overly muscled children and
youths can be classed as overweight or obese by BMI but
normal or healthy when based on body fat. Indeed, we
have used these body fat charts to demonstrate the extent
of misclassiﬁcation by BMI and in a sample of 1088
children aged between 5 and 13 years, 31% of individuals
were declared false negatives (i.e. excess body fat but
healthy BMI) and only 4% were rated as false positives
(normal fat but overweight BMI)(31). To emphasise, it is
the ‘hidden’ overfat children within the healthy BMI
range, which creates the under estimation of true over-
weight and obesity prevalence in surveillance systems
such as the National Child Measurement Programme.
Components of stature, obesity and chronic disease risk
Overall stature and the height component of BMI can be
divided into two simple components: trunk length and
leg length. The ratio of these two elements (expressed
as the leg length:height ratio) varies with age across
childhood and adolescence as well as varying between
the sexes and ethnic groups. Mean leg length:height
ratio increases between ages 5 and the pubertal stage,
at which point leg length:height ratio declines, illustrat-
ing the relative growth of the limbs and trunk at different
stages of child development(32). Proportionality is now
considered an additional dimension to how body size
and composition can inﬂuence chronic disease risk. For
example, components of cardiometabolic disease includ-
ing type 2 diabetes, hypertension, and non-alcoholic stea-
tohepatitis as well as overall CHD risk are associated
with having both absolute and relatively shorter legs as
well as shorter overall stature(33,34). Leg growth appears
to display a degree of plasticity in early life, with a
suggestion that a certain proportion of leg growth can
be sacriﬁced in favour of the growth of essential organs
such as the brain (whose impaired growth would have
far greater negative consequences) when pre- and early
post-natal energy and nutrient availability may be com-
promised. This plasticity of growth in response to nu-
tritional experience comprises a key element of the
thrifty phenotype hypothesis(35). However, caution must
be exercised when relating relative leg length to prior
early nutrition as it has been shown through nutritional
supplementation trials in undernourished populations,
that any increased growth in height as a result of sup-
plementation was due almost entirely to increases in
trunk length growth. However, the authors concluded
that it may be that the timing of dietary intervention is
crucial to inﬂuencing leg growth v. trunk growth(36).
Nevertheless, we have recently demonstrated that over-
weight and obesity in children and adolescents (assessed
by either BMI SD score (SDS) or WC SDS) is associated
with having relatively shorter legs (as illustrated by the
leg length:height ratio)(32). The corollary of this is that
overweight and obese children tend to have a greater
relative trunk length, therefore suggesting a greater po-
tential for higher truncal fat accumulation. Thus, altered
limb and trunk proportions appear to be linked to mea-
sures of overweight and obesity, again illustrating that
overweight/obesity, at least in part, can be a consequence
of altered patterns of growth(37). Thus, more epidemiolo-
gical studies of are incorporating measures of leg and
trunk length into study design and analyses, supported
by the availability of national references for leg length
and sitting height in children and adolescents(38).
Child and adolescent height for age and body fatness
Aside from the alterations in the components of stature
and proportionality, overweight and obese children
(deﬁned by their BMI SDS) also tend to be taller for
their age compared with non-overweight children, with
this observation even being seen in early childhood(32,39).
Thus, being tall for age could be considered an early
marker of risk for overweight and obesity. It had been
initially assumed that this height for age-overweight/
obese relationship was simply a characteristic of using
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BMI as the proxy measure for overweight/obesity, with
BMI tending to increase with increasing height and
that BMI preferentially classiﬁed taller children as over-
weight or obese. However, this height-for-age-increased
adiposity phenomenon has recently been conﬁrmed in a
small sample (280 children aged 7–12) in whom, body
composition was measured using dual energy X-ray
absorptiometry, a laboratory-based reference technique
that quantiﬁes tissue masses(40). Using the simpler ﬁeld-
based method of BIA, conducted in the community on
a larger sample (n 2298) of children and covering a
wider age range (4·5–14 years) we have conﬁrmed the
ﬁndings of the laboratory-based study that children who
are taller for their age also tend to have higher body fat
levels for their age(41). In this study, children were divided
into quartiles of height SDS, and mean percentage body
fat increased from 18·2% in the ﬁrst quartile, to 21% in
the fourth quartile. In addition, prevalence of overfat/
obesity increased from 9·4% in the ﬁrst quartile of
height-for-age, to 29·7% in the fourth quartile of height-
for-age. This height-for-age pattern of prevalence was
mirrored when BMI was used as the measure of over-
weight/obesity as well as when WC is used as the measure
of central overweight/obesity. It is possible that excess
weight and fat gain in childhood is driving additional
gains in height and suggests that if energy intake is
more than sufﬁcient to promote a rapid linear growth,
the excess may be stored as fat, resulting in a positive re-
lation between height and adiposity(39). This drive in
height growth is not a universal observation however, as
it must be remembered that overweight and obese chil-
dren were present (albeit to a lower extent) in the lower
quartiles of height-for-age and in their cases diet was
not driving height gain. However, caution must be exer-
cised when attempting to relate height for age (cross-
sectional) with growth rates (longitudinal) as genetics
(parental height) is the major determinant of height
growth with environment (diet) playing a minor part. In
addition, rapid linear growth might also lead to advanced
skeletal maturation(42). Advances in skeletal age in over-
weight or obese individuals appear to precede increases
in height, starting in mid-childhood, suggesting that fac-
tors involved with physical maturation are aetiologically
linked with overweight risk(43). Thus, childhood height
could be used to identify more accurately children who
may be likely to become overweight or obese in later
life, a suggestion previously proposed by others, where
height measurement could not only improve the identiﬁ-
cation of obese children but that special attention be
paid to children who have a high BMI and are also taller
for their age(43–45).
Socio-economic status, height-for-age and obesity
Risk for overweight and obesity is also strongly related
to socio-economic status, with children from a lower
income background demonstrating a higher prevalence
compared with children from a higher income back-
ground. When examining socio-economic status
inﬂuences on obesity prevalence, one overlooked
contributory factor is the shorter height-for-age in chil-
dren from a lower income background compared with
those from a higher income background. Thus, at similar
body weights across income groups, BMI would be
greater in children from a lower income background.
This shorter stature effect on BMI would be com-
pounded when body weight-for-age is higher compared
with those from a higher income background. However,
as discussed earlier, overweight and obese children tend
to be taller for age compared with children who are
of a healthy weight. Thus, for overweight and obese
children from a low-income background, there can be
opposing inﬂuences on their height-for-age. Employing
BIA to quantify adiposity, overfat/obese children from
a low-income background have been shown to be signiﬁ-
cantly taller than their healthy weight peers, but signiﬁ-
cantly shorter than overfat/obese children from a higher
income background(46). Similar income group differences
in height and hence BMI have also been observed in a
Canadian population, indicating this phenomenon to
be reproducible across population groups(47). Clearly,
shorter height is a second (and likely a more signiﬁcant)
contributor to the greater BMI, BMI z-score and over-
weight/obesity prevalence in lower income children.
These studies illustrate how height-for-age measurement
can reveal potential growth-related issues which can im-
pact on adiposity and risk for overweight/obesity.
Skeletal muscle, cardiometabolic disease and muscle
mass centile charts
Up to now, development of growth/body composition
assessment charts has focused on measures of adiposity,
especially as this tissue is a key driver of risk for cardio-
metabolic disease. However, skeletal muscle, which has
been largely overlooked in epidemiological and labora-
tory studies, is gaining greater recognition as an indepen-
dent marker of metabolic health, with muscle strength
for example, being positively related to greater insulin
sensitivity(48) and low muscle ﬁtness associated with
greater metabolic risk(49). Indeed, skeletal muscle is a
major site of insulin-mediated glucose disposal and there-
fore an important regulator of whole-body glucose
homoeostasis. Beyond metabolic health, sarcopenia
(age-related loss of muscle mass) is emerging as an im-
portant clinical and public health issue. Sarcopenia is
the major cause of decreased mobility and function in
old age, with quality of life diminishing due to a loss of
independent living. A key to delaying age-related SMM
loss is the optimal buildup of muscle across childhood
and adolescence and the maintenance of this mass
throughout adulthood(50), a pattern that has long been
recognised for maintaining bone mass and delaying the
risk for osteoporosis. Thus for clinical and epidemiologi-
cal purposes, it has become important to deﬁne and iden-
tify healthy (and by deﬁnition unhealthy) levels of SMM
in children and youths. However, due to the difﬁculty in
measuring SMM outside of the laboratory, there has
been a lack of age- and gender-speciﬁc normative data.
Using the same BIA technology used to develop the
H. David McCarthy214
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0029665113003868
Downloaded from https://www.cambridge.org/core. London Metropolitan University, on 08 Nov 2018 at 16:03:44, subject to the Cambridge Core terms of use, available at
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
UK body fat reference charts, (which has the ability to
produce regional or segmental body composition), we
have been able to quantify the SMM in the arms and
legs of children and youths (deﬁned as appendicular skel-
etal muscle mass (SMMa)) which acts as a good proxy
for whole-body SMM and to generate centile curves for
SMMa(51). Three formats of SMMa curves have been
constructed, which can be used to support different pur-
poses, namely absolute SMMa (kg), SMMa expressed as
a percentage of total body mass (%SMMa) and SMMa
as a percentage of fat-free mass (SMMa/fat-free mass
(kg)×100). In addition, centile curves for %fat-free mass
have been generated and reﬂect the reciprocal of %fat
mass (FM). Thus, users now have the opportunity to as-
sess body composition in children and youths against a
reference population with greater detail compared with
equivalent BMI charts. These charts can allow the track-
ing of SMMa in a clinical setting similar to the way height
and weight charts are currently used. The reference data
can also be used for epidemiological purposes. SMMa
charts have also been produced in a Canadian popu-
lation(52) and it is likely that we shall see them appearing
for different global child and youth populations in due
course. However, where BIA facilities for quantifying
SMMa are not available or appropriate, alternative and
simpler prediction tools need to be developed.
Thigh and hip circumference measurement
There is potential for thigh circumference (TC) to act as a
proxy for leg SMM. Approximately 75% of whole-body
SMM is found within the arms and legs, with the group
of muscles in the upper leg constituting a major fraction
of total leg muscle mass. A recent observation in adults
revealed that a smaller TC, which most likely reﬂects a
low thigh muscle mass is associated with the develop-
ment of cardiovascular morbidity and early mortality(53).
With this in mind, reference data for TC across child-
hood and adolescence could serve a useful purpose and
the ﬁrst set of TC charts for the UK paediatric popu-
lation have been developed(54). For completion, HC cen-
tile charts have also been developed in the UK(55), which
should prove valuable in the future, especially as NICE
guidelines on psychosis and schizophrenia in children
and young people (CG155) also recommend the
measurement of HC together with WC in patients receiv-
ing anti-psychotic pharmacotherapy(25).
Muscle:fat and waist:height ratios
Now that both FM and SMMa can be quantiﬁed with
reasonable accuracy in girls and boys across the age spec-
trum, this has facilitated the development of a new
potential measure of cardiometabolic risk, the muscle:
fat ratio (MFR). This measure, originally proposed by
Professor Andrew Prentice at the London School of
Hygiene and Tropical Medicine is based on the rationale
that FM and SMM have opposing effects on insulin sen-
sitivity and energy disposal, with the balance between
them more accurately able to determine cardiometabolic
risk beyond the ability of BMI. An individual having
both a low SMM and high FM would have a MFR
towards the low end of the MFR spectrum and may pres-
ent a risk for metabolic disease greater than having ex-
cess FM alone. We now have generated reference data
on the MFR distribution in boys and girls across child-
hood and adolescence(51). In our population, the mean
MFR in boys equals 1·99 (SD 0·60) with a range between
0·69 and 4·84. The equivalent values in girls are 1·38 (SD
0·40), range 0·49–3·22. In addition, MFR is signiﬁcantly
and positively age related in boys and negatively related
in girls. MFR also decreases with increase in BMI
z-score. An MFR of 1·25 in boys, 1·10 in younger girls
and 0·80 in older girls can be used to deﬁne the lower
limit of normal (mean minus 2 SD). It should however
be noted that since the gluteofemoral adipose mass has
been shown to be protective for metabolic health, the
relationships between MFR and metabolic disease risk
may be non-linear(56,57) and replacing the total body fat
with abdominal body fat in this ratio could further im-
prove this measure. However, this proposition also
needs to be systematically evaluated, although it is inter-
esting to note that a ratio of SMM to visceral fat area
ratio has been shown to be associated with metabolic
syndrome and arterial stiffness in a Korean elderly popu-
lation(58). This MFR follows a similar principle of the
more established waist:height ratio, which has been
shown to be effective across all ages and ethnicities as
a screening tool for the prediction of cardiovascular dis-
eases and type 2 diabetes, with a waist:height ratio of
0·50 performing as a suitable global boundary value(59).
Conclusions
Given the importance of cardiometabolic disease as
a major global public health and clinical condition,
a need has arisen for better tools to monitor individual
growth patterns, evaluate at-risk body composition and
identify those most at risk of developing the metabolic
components of the disease. A suite of individual mea-
sures, with national references, against which children
and youths can be assessed have now been produced.
Used collectively, they have the capacity to build a better
picture of an individual’s phenotype, which represents
their risk for cardiometabolic disease beyond that of
the capability of BMI. In the immediate future, most
likely some of these tools will ﬁnd greatest utilisation in
a research capacity where they can be better evaluated
and reﬁned. In time, the associations of these body
measures with components of the metabolic syndrome
should be better deﬁned through evaluation of their
sensitivity, speciﬁcity and validity. Through wider use
and awareness and their incorporation into clinical prac-
tice, they should be able to stimulate support by
policy makers at national and international levels.
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